main office



114 Cheyenne Way

Ottawa, On K2J 0E9

Jean-François Tanguay, MD, FRCPC, FCCS, FACC, FAHA, FESC

Dr Jean Francois Tanguay

Councillor - Université de Montréal

Jean-François Tanguay, MD, FRCPC, FCCS, FACC, FAHA, FESC

Dr. Jean-François Tanguay is an expert in Interventional Cardiology with a strong interest in translational research. He is involved in undergraduate and postgraduate medical training and CME education. Dr. Tanguay is Director of the Interventional Cardiology Division at the MHI and Clinical Cardiologist, combining work in the emergency room, the coronary care unit, the outpatient clinic and the catheterization laboratory (1995-ongoing). He is Director of the MD-PhD and Interventional Cardiology Training Programs and professor at the Faculty of Medicine of the Université de Montréal.

He was President of the Canadian Interventional Cardiology Association (2002-2005) and Director of the Interventional Cardiology Montreal Symposium (2004-2015). He is Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC), the Canadian Cardiovascular Society (FCCS), the American Heart Association (FAHA), the American College of Cardiology (FACC), and the European Society of Cardiology (FESC). He is Co-Chair of the CCS Anti Platelet Guidelines Committee and their guidelines’ recommendations were published in the Canadian Journal of Cardiology in 2011, 2013, and 2018.

His research is focus on understanding the interactions between platelets, leukocytes and endothelial cells in order to improve vascular healing. Dr. Tanguay’s investigations brought promising discoveries related to 17beta-estradiol and the specific contribution of estrogen receptors in vascular healing. During his research fellowship, Dr Tanguay studied the early prototypes of bioresorbable drug eluting stents platforms in pre-clinical and thrombosis models. With his colleagues at MHI, he performed the first coronary implantation of a drug-eluting bioresorbable scaffold (ABSORBTM) in North-America.

Dr. Tanguay is member of steering committees for NIH-, CIHR- and industry-sponsored clinical trials. He has written more than 200 papers in peer-reviewed journals, 6 book chapters & guidelines, and more than 250 abstracts & posters. He has given more than 200 invited lectures or oral presentations at national and international scientific meetings. His research team received more than $40 million from academic and from other granting agencies.

In addition to his clinical, teaching and research background, he is the father of four sons, and has been happily married for 28 years.